Ignite Creation Date:
2025-12-24 @ 2:16 PM
Ignite Modification Date:
2026-01-01 @ 2:07 PM
Study NCT ID:
NCT07108595
Status:
COMPLETED
Last Update Posted:
2025-08-07
First Post:
2025-07-31
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of T-DXd in Patients With HER2-positive and HER2-low Metastatic Breast Cancer: a Real-world Study
Sponsor:
The First Affiliated Hospital with Nanjing Medical University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-01-01
Start Date Type:
ACTUAL
Primary Completion Date:
2024-08-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-12-31
Completion Date Type:
ACTUAL
First Submit Date:
2025-07-31
First Submit QC Date:
None
Study First Post Date:
2025-08-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-31
Last Update Post Date:
2025-08-07
Last Update Post Date Type:
ACTUAL